Should We Stop Saying 'Glia' and 'Neuroinflammation'?

Area of Science:

• Neuroscience
• Cell Biology

Background:

• Current central nervous system (CNS) therapeutics based on neuroinflammation have shown limited success.
• The term 'neuroinflammation' may be an inaccurate or obsolete concept for explaining CNS disease pathology.

Purpose of the Study:

• To challenge the conventional understanding of neuroinflammation in CNS diseases.
• To propose a new framework for understanding CNS diseases and developing therapies.

Main Methods:

• Unbiased molecular profiling of CNS cell populations and individual cells.
• Analysis of phenotypic heterogeneity in glial cells (astrocytes, microglia, oligodendrocytes, NG2 cells) in health and disease.

Main Results:

• Striking phenotypic heterogeneity observed in CNS cells, both in health and disease states.
• Glial cells demonstrate functions beyond basic housekeeping, potentially contributing to higher-brain functions.

Conclusions:

• The terms 'neuroinflammation' and 'glia' may require re-evaluation due to cellular complexity.
• CNS diseases could be conceptualized as failed circuits resulting from disease-specific glial cell dysfunction.
• Therapies should focus on promoting functional recovery of these cells rather than solely targeting inflammation.